ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 116 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | -50.1% | 32,784 | -30.0% | 0.20% | -59.9% |
| Q3 2020 | $499,000 | -34.2% | 46,834 | -6.3% | 0.51% | -37.8% |
| Q2 2020 | $758,000 | +305.3% | 50,000 | +122.2% | 0.82% | +145.1% |
| Q1 2020 | $187,000 | -50.8% | 22,500 | 0.0% | 0.34% | -47.3% |
| Q4 2019 | $380,000 | -38.9% | 22,500 | -32.8% | 0.64% | +1.9% |
| Q3 2019 | $622,000 | -51.0% | 33,500 | -39.6% | 0.62% | -63.7% |
| Q2 2019 | $1,270,000 | -20.7% | 55,502 | -27.1% | 1.72% | -43.6% |
| Q1 2019 | $1,601,000 | -25.1% | 76,170 | -59.0% | 3.05% | -36.9% |
| Q4 2018 | $2,138,000 | +277.7% | 185,848 | +654.0% | 4.83% | +489.9% |
| Q3 2018 | $566,000 | +149.3% | 24,648 | +184.0% | 0.82% | +164.2% |
| Q4 2017 | $227,000 | -65.3% | 8,678 | -70.3% | 0.31% | -65.4% |
| Q3 2017 | $655,000 | -17.9% | 29,186 | 0.0% | 0.90% | -23.5% |
| Q2 2017 | $798,000 | -13.6% | 29,186 | -23.6% | 1.17% | -16.2% |
| Q1 2017 | $924,000 | +122.7% | 38,186 | +90.9% | 1.40% | +129.0% |
| Q4 2016 | $415,000 | – | 20,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $49,965,000 | 30.39% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,356,363 | $99,674,000 | 21.44% |
| Selkirk Management LLC | 348,805 | $7,981,000 | 4.29% |
| Trellus Management Company, LLC | 55,502 | $1,270,000 | 1.72% |
| GRIFFIN ASSET MANAGEMENT, INC. | 550,046 | $12,585,000 | 1.60% |
| Belpointe Asset Management LLC | 272,459 | $6,234,000 | 1.23% |
| Cannell & Co. | 1,115,239 | $25,517,000 | 0.97% |
| CHARTIST INC /CA/ | 64,765 | $1,481,823,000 | 0.94% |
| Chicago Capital, LLC | 546,279 | $12,499,000 | 0.80% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,546,000 | 0.76% |